BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
0.1437
-0.0580 (-28.76%)
At close: Sep 3, 2026, 4:00 PM EDT
0.1457
+0.0020 (1.39%)
Pre-market: Sep 4, 2026, 6:36 AM EDT
BioRestorative Therapies Employees
As of December 31, 2025, BioRestorative Therapies had 14 total employees, including 13 full-time and 1 part-time employees. The number of employees increased by 3 or 27.27% compared to the previous year.
Employees
14
Change (1Y)
3
Growth (1Y)
27.27%
Revenue / Employee
$25,562
Profits / Employee
-$789,756
Market Cap
3.66M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 14 | 3 | 27.27% | 13 | 1 |
| Dec 31, 2024 | 11 | 0 | - | 11 | 0 |
| Dec 31, 2023 | 11 | 1 | 10.00% | 11 | 0 |
| Dec 31, 2022 | 10 | 3 | 42.86% | 10 | 0 |
| Dec 31, 2021 | 7 | 2 | 40.00% | 7 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| GeoVax Labs | 19 |
| Cardio Diagnostics Holdings | 17 |
| Processa Pharmaceuticals | 12 |
| NuCana | 12 |
| Dermata Therapeutics | 9 |
| Cadrenal Therapeutics | 5 |
| Kairos Pharma | 4 |
| PharmaCyte Biotech | 2 |
BRTX News
- 1 day ago - BioRestorative Therapies announces 1-for-20 reverse stock split - TheFly
- 1 day ago - BioRestorative Therapies Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - BioRestorative Therapies completes manufacturing for BRTX-100 - TheFly
- 2 months ago - BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform - GlobeNewsWire
- 2 months ago - BioRestorative Therapies Slides: Corporate presentation - Filings
- 2 months ago - BioRestorative Therapies appoints Smith as VP of Biocosmeceuticals Division - TheFly
- 2 months ago - BioRestorative Therapies Strengthens Leadership with Appointment of Healthcare Executive Zachary Smith as Vice President of Biocosmeceuticals Division to Accelerate Commercial Expansion and Strategic Growth - GlobeNewsWire
- 3 months ago - BioRestorative Therapies Slides: Corporate presentation - Filings